JP2005539031A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005539031A5 JP2005539031A5 JP2004529471A JP2004529471A JP2005539031A5 JP 2005539031 A5 JP2005539031 A5 JP 2005539031A5 JP 2004529471 A JP2004529471 A JP 2004529471A JP 2004529471 A JP2004529471 A JP 2004529471A JP 2005539031 A5 JP2005539031 A5 JP 2005539031A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amino acid
- composition according
- mutation
- enos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40363702P | 2002-08-16 | 2002-08-16 | |
| PCT/US2003/025626 WO2004016761A2 (en) | 2002-08-16 | 2003-08-15 | Gene therapy for critical limb ischemia with wild type or mutant enos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005539031A JP2005539031A (ja) | 2005-12-22 |
| JP2005539031A5 true JP2005539031A5 (enExample) | 2006-09-28 |
Family
ID=31888259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004529471A Pending JP2005539031A (ja) | 2002-08-16 | 2003-08-15 | 野生型または変異型ｅＮＯＳによる重症肢虚血の遺伝子療法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040120930A1 (enExample) |
| EP (1) | EP1536689A4 (enExample) |
| JP (1) | JP2005539031A (enExample) |
| KR (1) | KR20050042162A (enExample) |
| CN (2) | CN101391105A (enExample) |
| AU (1) | AU2003263844A1 (enExample) |
| BR (1) | BR0313515A (enExample) |
| CA (1) | CA2494845A1 (enExample) |
| IL (1) | IL166362A0 (enExample) |
| MX (1) | MXPA05001763A (enExample) |
| NO (1) | NO20051351L (enExample) |
| PL (1) | PL375446A1 (enExample) |
| RU (1) | RU2005107414A (enExample) |
| WO (1) | WO2004016761A2 (enExample) |
| ZA (1) | ZA200502181B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150359862A1 (en) * | 2013-01-30 | 2015-12-17 | Board Of Regents Of The University Of Nebraska | Compositions and Methods for Treating Complications Associated with Diabetes |
| CA3025146A1 (en) * | 2016-04-29 | 2017-11-02 | Inovio Pharmaceuticals, Inc. | The in vivo use of chondroitinase and/or hyaluronidase to enhance delivery of an agent |
| CN105944243A (zh) * | 2016-05-12 | 2016-09-21 | 段俊丽 | 一种eNOS表达与活化的调控装置及周围动脉疾病的治疗装置 |
| IL270388B2 (en) * | 2017-05-02 | 2024-03-01 | Univ Miami | A method for treating ischemic tissue |
| CN107802826B (zh) * | 2017-10-26 | 2020-02-18 | 首都医科大学宣武医院 | eNOS突变体在促进血管生成中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002506008A (ja) * | 1998-03-09 | 2002-02-26 | セント エリザベス メディカル センター | 血管新生を調整するための組成物及び方法 |
| EP1016726A1 (en) * | 1998-12-30 | 2000-07-05 | Introgene B.V. | Gene therapy to promote angiogenesis |
| SK14692001A3 (sk) * | 1999-04-16 | 2002-09-10 | Yale University | Izolovaná molekula nukleovej kyseliny, izolovaný NOS polypeptid, spôsob stimulácie, spôsob liečby, spôsob identifikácie a nehumánne transgénne zviera |
-
2003
- 2003-08-15 KR KR1020057002657A patent/KR20050042162A/ko not_active Ceased
- 2003-08-15 US US10/642,255 patent/US20040120930A1/en not_active Abandoned
- 2003-08-15 WO PCT/US2003/025626 patent/WO2004016761A2/en not_active Ceased
- 2003-08-15 AU AU2003263844A patent/AU2003263844A1/en not_active Abandoned
- 2003-08-15 CN CNA2008101259592A patent/CN101391105A/zh active Pending
- 2003-08-15 EP EP03788540A patent/EP1536689A4/en not_active Withdrawn
- 2003-08-15 RU RU2005107414/13A patent/RU2005107414A/ru not_active Application Discontinuation
- 2003-08-15 MX MXPA05001763A patent/MXPA05001763A/es not_active Application Discontinuation
- 2003-08-15 JP JP2004529471A patent/JP2005539031A/ja active Pending
- 2003-08-15 PL PL03375446A patent/PL375446A1/xx not_active Application Discontinuation
- 2003-08-15 CN CNB038194945A patent/CN100408101C/zh not_active Expired - Fee Related
- 2003-08-15 BR BR0313515-2A patent/BR0313515A/pt not_active IP Right Cessation
- 2003-08-15 CA CA002494845A patent/CA2494845A1/en not_active Abandoned
-
2005
- 2005-01-18 IL IL16636205A patent/IL166362A0/xx unknown
- 2005-03-15 NO NO20051351A patent/NO20051351L/no not_active Application Discontinuation
- 2005-03-15 ZA ZA200502181A patent/ZA200502181B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2507507T3 (es) | Células madre mesenquimales CD34 negativas modificadas genéticamente para el tratamiento de tumores | |
| Song et al. | Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP | |
| RU2448159C1 (ru) | Лечение и предупреждение болезней сердца с использованием двух или более изоформ фактора роста гепатоцитов | |
| ES2556711T3 (es) | Formulaciones liofilizadas de ADN para el aumento de la expresión del ADN plasmídico | |
| Jiang et al. | Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells | |
| Haider et al. | Angiomyogenesis for myocardial repair | |
| JP2005539031A5 (enExample) | ||
| Sim et al. | Therapeutic angiogenesis for coronary artery disease | |
| Preda et al. | Evaluation of gene and cell-based therapies for cardiac regeneration | |
| RU2005107414A (ru) | Генная терапия критической ишемии конечностей с использованием эндотелиальной синтазы оксида азота (enos) дикого типа или мутантной | |
| Pagliari et al. | Adult stem cells and biocompatible scaffolds as smart drug delivery tools for cardiac tissue repair | |
| Shafiq et al. | Biomaterials for host cell recruitment and stem cell fate modulation for tissue regeneration: focus on neuropeptide substance P | |
| US20030148952A1 (en) | Methods and materials for the recruitment of endothelial cells | |
| Roncalli et al. | Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure | |
| Sanganalmath et al. | The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up | |
| JP4775663B2 (ja) | 血管新生制御方法 | |
| Samatoshenkov | STIMULATION OF RAT SKELETAL MUSCLE ANGIOGENESIS BY DIRECT AND CELL-MEDIATED ADMINISTRATION OF RECOMBINANT ANGIOGENIN GENE | |
| Paulsen et al. | ANGIOGENIC CYTOKINES IN THE TREATMENT OF ISCHEMIC HEART DISEASE | |
| Pelacho et al. | Molecular Intervention with Plasma-Rich Growth Factors to Enhance Muscle Perfusion and Tissue Remodeling in Ischemic Diseases | |
| Forte | Adult stem cells and biocompatible scaffolds as smart drug delivery tools for cardiac tissue repair | |
| US20050260161A1 (en) | Method for modulating, regulating and/or stabilizing angiogenesis | |
| M. Lasso et al. | Application of VEGF Gene Therapy in Two Basic Fields of Plastic-Reparative Surgery: Tissue Reconstruction with Flaps and Peripheral Nerve Surgery | |
| Chandler et al. | Matrix-Enabled Gene Delivery for Tissue Repair | |
| Kornowski | INTRAMYOCARDIAL GENE AND CELLULAR DELIVERY FOR MYOCARDIAL ANGIOGENESIS AND REGENERATION | |
| HK1150779A (en) | Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |